Who We Are.
At Acutus Medical, our goal is simple: create superior outcomes for patients with complex atrial arrhythmias. We deeply understand the effects that complex atrial arrhythmias have on people’s lives, which is why we’ve pioneered an advanced intracardiac mapping system featuring dynamic arrhythmia visualization. Our platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists.
Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, CA. Our products are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.
Vince BurgessChairman, President and CEO
Vince Burgess is a Venture Partner with OrbiMed. Mr. Burgess has over 20 years of experience in healthcare operations, business development and venture capital.
Vince was on the founding executive team at Volcano, where he was President, Advanced Imaging Systems, and also led marketing and business development from 2002 to 2010. At Volcano, he was a key architect of the company’s product, marketing and M&A strategies. During his tenure, Volcano grew from a start-up to a global company with over 1,000 employees and a market cap of over $1.2 billion.
Mr. Burgess previously served as a partner of Sorrento Ventures and has operational and board experience in the surgical tool, ophthalmology and healthcare I.T. fields. Mr. Burgess earned his M.B.A. at UCLA and his B.S. in Business Administration from USC.
Mike IversenChief Commercial Officer
Mike Iversen joined Acutus Medical in 2018 with more than two decades of experience in the cardiac industry. His expertise spans pricing and contracting, segmentation and pricing strategy for new segments.
Over the course of his career, Iversen delivered a new therapy category and lobbied to create the reimbursement codes for heart failure (CRT) therapy. Additionally, he recruited a sales force for a small therapy business and grew it from $60 million to $400 million in a decade. Previously, Iversen held leadership positions at BIOTRONIK and Boston Scientific. He also led market development for an international automotive company’s European division.
Iversen holds an MBA from University of Michigan and resides in Coronado, CA.
Peter EliaHEAD OF BUSINESS AND MARKET DEVELOPMENT
Peter Elia joined Acutus Medical with 25 years of experience in the electrophysiology field. His expertise includes sales, market development, acquisitions and partnerships.
An entrepreneur at heart, Elia worked with a start-up CPI, later named Guidant, which was acquired by Boston Scientific. Before he turned 32, he became a national sales leader, overseeing 400 staff and $400 million in sales revenue. Together with a core business partnership, he created a unique sales organization within a tier 3 company and grew their market share as a distant fourth player with 2% share, to an innovative growth hacker, with 10% share over seven years.
Elia has a BS from San Diego State University and lives in Coronado, California.
Graydon Beatty, PhDChief Technology Officer
Dr. Beatty has over 25 years of experience in the design and development of innovative products for the field of cardiac electrophysiology. He has distinguished himself as a scientific and clinical partner with leading physicians worldwide and is considered an expert in the electrical properties of excitable tissue and the biophysics of ablation energy delivery.
Prior to joining Acutus Medical, Dr. Beatty was co-founder and Chief Technical Officer at Endocardial Solutions, Inc., which developed a 3D cardiac mapping and navigation system. ESI was subsequently sold to St. Jude Medical where Dr. Beatty served as Vice President, Therapy Delivery. Dr. Beatty has held several other development and management roles with the USCI and Electrophysiology divisions of CR Bard, Cardiac Pacemakers, Inc. (Now Boston Scientific), Angemed Corporation and EP Technologies (Now Boston Scientific).
Dr. Beatty earned his BS degree in Electrical Engineering and MS and PhD degrees in Biomedical Engineering from the Universities of Minnesota and Wisconsin. He has over 50 issued U.S. patents in various medical technology fields.
Dave BrengleChief Operating Officer
Mr. Brengle is a seasoned executive with over 25 years of experience in companies from small start-ups to Fortune 50 in size. He has extensive experience in Global Operations, Lean Manufacturing practices, new product and process development and scale up as well as acquisitions and integrations.
Mr. Brengle has previously held senior level Operations and Product Development positions with several medical device companies including Breg, Cardinal Health, Tandem Medical, Alaris, River Medical, Block Medical and InterVentional Technologies.
Mr. Brengle holds a BS. degree in Applied Mechanics and Engineering Science from U.C. San Diego and a MBA from San Diego State.
Tim CorviVice President, Research and Development
Mr. Corvi is a seasoned research and development professional with over 20 years of experience in the design and development of devices for interventional cardiology, cardiovascular surgery, drug infusion and cardiac electrophysiology.
Previous to joining Acutus Medical, Mr. Corvi was Director of Engineering at Ablation Frontiers, which was acquired by Medtronic, Inc. in 2009. Throughout his career, Mr. Corvi has been an integral team member within multiple early stage medical device start-ups including Devices for Vascular Intervention, Heartport and FoxHollow Technologies where he held various positions from Design Engineer to Project Manager.
Mr. Corvi holds a BS degree in Mechanical Engineering from the University of California, San Diego. He is listed as primary or co-inventor on over 20 issued and pending US patents.
Gary W. DohertyChief Financial Officer
Gary W. Doherty has more than 27 years in operational finance, strategic corporate financial planning and forecasting, project management and systems development.
Before joining Acutus, Mr. Doherty served as Group Plant Controller and Director of Cost Accounting over the span of 10 years at Volcano Corporation, which was acquired by Philips NV in 2015. At Volcano, he was a key team member in the 2008 acquisition of Axsun Technologies and for efforts around the construction of a new factory in Santa Jose, Costa Rica. During his career, Mr. Doherty has also helped lead the financial operations of several other technology companies, including medical imaging company Digirad Incorporated, high-tech conglomerate Palomar Technologies and diagnostic electronics manufacturer Nellcor Incorporated.
He earned his Bachelor of Science in Business Administration with an emphasis in Finance at San Diego State University.
J. Christopher FlahertyIntellectual Property
J. Christopher Flaherty has 25 years of experience in the medical device field, with over 150 issued U.S. Patents to his name.
In the past 15 years, Mr. Flaherty has managed the intellectual property portfolio for numerous medical device companies including Ablation Frontiers, Rox Medical, Medrobotics Corporation, and Fractyl Technologies.
Mr. Flaherty founded Insulet Corporation (NASDAQ:PODD) in 2000, and co-founded TransVascular Inc in 1996.
Mr. Flaherty has been an invited speaker at the United States Patent and Trademark Office, presenting new technologies. He earned a B.S. in Avionics Engineering from MIT in 1985, where he won the Luis de Florez award for inventiveness.
Tim GlynnVice President of Sales and Market Development
Mr. Glynn is a resourceful leader with 20 years of experience in all stages of medical device development and commercialization for both capital equipment and disposable products. With Acutus Medical since 2014, Mr. Glynn served as the Managing Director in Europe where he built out the European business and infrastructure including the hiring and management of Sales, Marketing, and Operations.
Prior to joining Acutus, Mr. Glynn was with Volcano Corporation for 11 years, where he developed flagship products and managed global launch initiatives contributing to the company’s growth until it was acquired by Philips N.V.
Mr. Glynn completed Harvard Business School’s Management Development Program and previously earned an Applied Science degree in Electronics at Suffolk College, followed by a B.S. in Nursing from Stony Brook University where he gained clinical experience in interventional cardiology.
Steven McQuillanSenior Vice President, Regulatory and Clinical Affairs
Mr. McQuillan is an experienced clinical and regulatory affairs professional with over 25 years of clinical trial design, execution and understanding of the global medical device regulatory environment. He has successfully obtained US and International Class III medical device approvals and been involved in more than 30 IDE and significant risk clinical trials and publications.
Mr. McQuillan has held several key leadership positions including the University of Minnesota, Department of Surgery, CPI/Guidant, Boston Scientific, Medtronic (Atrial Fibrillation Solutions) and Spinal Modulation (recently acquired by St. Jude Medical).
Mr. McQuillan holds degrees in Engineering Statistics and Biostatistics from the University of Minnesota.
Board of Directors
Dr. David BonitaPrivate Equity Partner at OrbiMed
Dr. David Bonita is a Private Equity Partner at OrbiMed, where he serves on the boards of Loxo Oncology, Kyn Therapeutics, Clementia Pharmaceuticals, Tricida, Prelude Therapeutics, ViewRay, SI Bone and Keystone Heart. He previously served on the boards of Enobia Pharma, CardiAQ and Ambit Bioscience. Prior to joining OrbiMed, Dr. Bonita worked in the healthcare investment banking groups of Morgan Stanley and UBS. He has published several scientific articles in peer-reviewed journals based on research performed at the Harvard Medical School. Dr. Bonita received his A.B. degree magna cum laude in Biological Sciences from Harvard University and his joint M.D./M.B.A. from Columbia University where he was elected to the Alpha Omega Alpha Medical Honor Society and Beta Gamma Sigma Business Honor Society.
Vince BurgessVenture Partner with OrbiMed
Vince Burgess is a Venture Partner with OrbiMed. Mr. Burgess has over 20 years of experience in healthcare operations, business development and venture capital. Vince was on the founding executive team at Volcano, where he was President, Advanced Imaging Systems, and also led marketing and business development from 2002 to 2010. At Volcano, he was a key architect of the company’s product, marketing and M&A strategies. During his tenure, Volcano grew from a start-up to a global company with over 1,000 employees and a market cap of over $1.2 billion. Mr. Burgess previously served as a partner of Sorrento Ventures and has operational and board experience in the surgical tool, ophthalmology and healthcare I.T. fields. Mr. Burgess earned his M.B.A. at UCLA and his B.S. in Business Administration from USC.
Dr. Andrew ElBardissiInvestor on the Private Transaction team at Deerfield Management
Dr. Andrew ElBardissi is an investor on the Private Transaction team at Deerfield Management. Prior to joining Deerfield, Dr. ElBardissi held roles as an early stage life-sciences investor at Longitude Capital and as an Investment Banker at J.P. Morgan’s Healthcare practice. Dr. ElBardissi holds an M.D. from the Mayo Clinic, an M.P.H. in Quantitative Methods from Harvard University, an M.B.A. from Harvard Business School. He received residency training in General Surgery at Harvard Medical School’s Brigham and Women’s Hospital and in Cardiothoracic Surgery at Stanford University. Dr. ElBardissi has been independently funded by the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ), has over 30 publications in leading peer reviewed scientific journals, and has presented his research at numerous medical and surgical conferences.
Shahzad MalikGeneral Partner at Advent Life Sciences
Shahzad Malik is a General Partner at Advent Life Sciences which he joined in 1999. He came to Advent with a strong grounding in science and clinical medicine. Prior to joining Advent he spent six years practicing medicine, before joining McKinsey & Company. Here he served international clients in the Healthcare and Investment Banking sectors. During his time with Advent he has been actively involved with numerous investments in Europe and the United States in the biopharmaceutical and medical device arenas. Shahzad gained an MA from Oxford University and an MD from Cambridge University. He subsequently specialized in interventional cardiology while also pursuing research interests in heart muscle disorders both in the clinic and basic science laboratory.
Aditya PuriInvestment Partner at Xeraya Capital
Aditya Puri is an Investment Partner at Xeraya Capital, which is responsible for life sciences investments for Khazanah Nasional Berhad, the Malaysian government’s strategic investment fund. He joined Khazanah Nasional’s Life Sciences team after moving from the greater Boston area where he was working with Healthcare and Cleantech startups affiliated with Harvard and MIT. He has more than 20 years of experience and leadership encompassing general management, private equity and venture investments, and international expansion across life science and technology industries. His prior experience includes P&L responsibility and leadership positions at Yankee Group, a global technology research and consulting company, and Corporate Development at Boston Scientific, a Fortune 500 medical device manufacturer. He serves on Boards of multiple public and private life sciences companies in the US, and private companies outside the US. He received his B.S. from the University of Southern Maine, graduating Summa Cum Laude, and his MBA from the MIT Sloan School of Management. He has also passed all parts of the U.S. Uniform CPA Examination.
Dr. Christoph ScharfSwiss physician with a specialty in Internal Medicine and Cardiology
Dr. Christoph Scharf is a Swiss physician with a specialty in Internal Medicine and Cardiology. He has been working in Paris, France, Goundi, Chad, Ann Arbor, Michigan and since 2005 has worked in a private electrophysiology practice in Clinic im Park, Zurich, which is the largest EP center in Switzerland. In addition, Dr. Scharf is the co-founder of Acutus Medical.
If you are interested in helping patients with complex atrial arrhythmias, we are interested in talking with you. We are searching for extraordinary individuals who thrive in a fast-paced, collaborative environment. We offer a full range of benefits including medical/dental/vision/life insurance, paid time off and stock options, along with competitive salaries.Current Openings
Acutus Medical, Inc.
2210 Faraday Ave. Suite 100
Carlsbad, CA 92008
United States of America
Acutus Medical NV
Phone: +32 2 669 75 00
Fax: +32 2 669 75 01